Sci Pharmtech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021
May 06, 2021 at 12:57 pm EDT
Share
SCI Pharmtech, Inc. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was TWD 323.626 million compared to TWD 784.328 million a year ago. Operating income was TWD 57.354 million compared to TWD 280.202 million a year ago. Net income was TWD 41.673 million compared to TWD 208.331 million a year ago. Basic earnings per share from continuing operations was TWD 0.52 compared to TWD 2.62 a year ago. Diluted earnings per share from continuing operations was TWD 0.52 compared to TWD 2.6 a year ago.
SCI Pharmtech, Inc. is a Taiwan-based company principally engaged in the processing, manufacture and sales of Active Pharmaceutical Ingredients (APIs). The Company's main products include APIs, API intermediates and special and precision chemicals. The Company distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others
SCI PHARMTECH, INC. 